Wai Chun Group Holdings Limited announced resignation of Lam Ching Kui as chief executive officer. Mr. Lam Ka Chun ("Mr. Lam") has been appointed as chairman, chief executive officer
and executive director of the Company with effect from 27 October 2023. Mr. Lam, aged 32, has been managing directors of the Company and Wai Chun Bio- Technology Limited (stock code: 660) (a company listed on the Main Board of the Stock Exchange) since 2017 and is responsible for the investment and operation of the listed companies. Mr. Lam served as chief executive officer in various companies from 2011 to 2017 and has accumulated extensive experience in projects investment and management. Mr. Lam studied chemistry at Imperial College London from 2009 to 2011. Mr. Lam is the son of Mr. Lam Ching Kui. As at the date of this announcement, Ka Chun Holdings Limited, the substantial shareholder of the Company within the meaning of Part
XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) (the "SFO") and the controlling shareholder of the Company, is wholly owned by Wai Chun Investment Fund. Wai Chun Investment Fund is wholly owned by Mr. Lam Ching Kui. Mr. Lam joined Wai Chun Bio-Technology Limited, a listed Company in the Main Board of the Stock Exchange of Hong Kong Limited (stock code: 660) as an executive director since 13 March 2023.